Technoclone GmbH of Wien at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Technoclone GmbH

Brunner Str. 67, 1230 Wien
Telephone +43 1 863730
Fax +43 1 89637344

This company is co-exhibitor of
ADVANTAGE AUSTRIA Wirtschaftskammer Österreich

Hall map

MEDICA 2018 hall map (Hall 3): stand F56

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.07  Other diagnostics

Our products

Product category: Other diagnostics

Global Tests - Prothrombin Time (PT)

The TECHNOPLASTIN® HIS and TECHNOCLOT® PT Series are thromboplastin reagents derived from rabbit. Thromboplastins are a mixture of tissue factor, phospholipid, and calcium.

The Prothrombin Time (PT) is used to:

· Screen for congenital or acquired deficiencies in the extrinsic and common pathways

· Monitor warfarin therapy

· Aid in the diagnosis of DIC

· Aid in the diagnosis of inhibitors to Factors II, V, and X

For warfarin monitoring the most common reporting method is the INR; in certain countries an alternative normalization method known as the Prothrombin percent activity, is used.

The TECHNOCLOT® PT Owren is a thromboplastin reagent modified according to Owren. The reagent is enriched with bovine plasma from which the prothrombin complex factors II, VII and X have been removed by adsorption. The bovine plasma remains a source of fibrinogen and factor V, therefore cannot abnormalities in these proteins be detected by the test.

The reagent is available in two formats, one for the manual method and one for automated use on coagulation analyzer.

More Less

About us

Company details

"On the forefront of diagnostic challenges of tomorrow"
Technoclone Herstellung von Diagnostika und Arzneimitteln  GmbH was founded in 1987 by Prof. Dr. Bernd R. Binder (1945 - 2010). The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibind) in the field of fibrinolysis.

Acquisition of the former Immuno diagnostics portfolio from the Baxter AG

From 1998 on Technoclone expanded rapidly through the acquisition of the former Immuno diagnostics from Baxter AG and the establishment of an distribution system all over the world.

Production and OEM Products

Technoclone is a world-leading producer of diagnostics tests, equipments and research products in the area of blood clotting. It offers both global as well as speciality coagulation tests. With the fully automated coagulation analyzer the Ceveron® alpha and the semi-automated analyzers the Ceveron® one, four and ten the portfolio was completed. The Ceveron® alpha TGA offers the unique feature of a fully automated thrombin generationmeasurement in the routine: CV <5% and assay times <20min Peak Thrombin. Furthermore Technoclone provides a complete range for ADAMTS-13 testing, as well a complete portfolio for the new anticoagulants (DOAC´s) such as for Xa inhibitors and direct thrombin inhibitors.

Technoclone´s high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogues of international diagnostics companies.

Research & Development

The focus of Technoclone´s research and development is in the field of thrombosis and cardiovascular diseases, the world leading cause of mortality and morbidity. Research and development is pursued in Technoclone´s own research division and in close cooperation with Universities and international and national research consortia. Technoclone holds at present more than 10 international patents in the field of diagnosis and therapy of vascular diseases.

More Less